Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
NCT00830193Phase 3Completed
- Sponsor
- Unity Health Toronto
- Start
- Aug 2002
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in contrast-induced nephropathy (CIN), sponsored by Unity Health Toronto. Started Aug 2002; status: completed.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00830193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830193.